Sramana Mitra: I’m just trying to understand the trends of this industry. If a technology provider is selling into the pharmaceutical industry in the digital therapeutics use case, how else is a digital therapeutics use case going to pan out commercially? Raj Agarwal: It’s early in the game. That’s a new trend. There are three
Sramana Mitra: Let’s switch the discussion to pharmaceuticals and where drugs are now being enhanced by various kinds of digital monitoring or reporting. What are the trends there? It seems like you have penetration in that use case as well. Raj Agarwal: One big trend on the pharma side is that they are recognizing that
Sramana Mitra: Let me paraphrase my question and see if you can answer them from a trend point of view. On the value-based care side, whether it’s hospitals or physicians, what trends are you seeing in terms of adoption? How aggressive is the adoption of technologies such as yours? Raj Agarwal: Frankly, it’s the slowest
Raj Agarwal: What we have done uniquely is combine all four aspects into one single platform. It’s seamless and integrated to allow multi-party connectivity. You can add family members or caregivers and engage in a meaningful way. This is targeted more for complex and high-care chronic conditions. At the heart of what we do is
Mega trends are sweeping through the healthcare space driven by the impact of digital technology. In this conversation, we kick around value-based healthcare, digital therapeutics, etc. and how Medocity is adding value to those use cases. Sramana Mitra: Let’s start by introducing yourself and Medocity. Raj Agarwal: I’m the President and CEO of Medocity. We